author-photo

Richa Dua

10

Papers

212

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Abstract LB050: Modulation of innate and adaptive immunity in blood and tumor of patients receiving the SHP2 inhibitor RMC-4630

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB054: Confirmation of target inhibition and anti-tumor activity of the SHP2 inhibitor RMC-4630 via longitudinal analysis of ctDNA in a phase 1 clinical study

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB001: Anti-tumor activity and tolerability of the SHP2 inhibitor RMC-4630 as a single agent in patients with RAS-addicted solid cancers

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Long-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Clowning in Dental Health Care Settings: The Point of View of Dental Student

2017
Show All
- Source
- Cite
- Save
Citations (0)
Clown language training in Dental education: Dental Student’s Perspective

2017
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study

2017 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

2017 The Lancet
Show All
- Source
- Cite
- Save
Citations (195)